FDA Clearance Tracker · P100014-S031
Solesta (Injectable Gel)
Last checked: Nov 20, 2026Latest source record: Oct 27, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Oct 27, 2021
Approved
Time to decision
177 days
Received May 3, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P100014-S031
- Device name
- Solesta (Injectable Gel)
- Applicant
- Palette Life Sciences
- Applicant location
- Santa Barbara, CA
- Received
- May 3, 2021
- Decided
- Oct 27, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P100014
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
Approval to implement electronic labeling and changes to the labeling including revised contraindication, new warnings and new precautions.
Source documents
Other decisions for Palette Life Sciences
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Barrigel Injectable Gel510(k)
K220641 · Decided May 26, 2022 · 83 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.